Stage IVA Colon Cancer AJCC v8

Explore clinical trials studying Stage IVA Colon Cancer AJCC v8. Study availability and eligibility vary by location and protocol.

7 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Stage IVA Colon Cancer AJCC v8 trial results

Recruiting

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

NCT05296681

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +13 more
Locations: Robert Wood Johnson University Hospital, Hamilton Hamilton, New Jersey, United States

Monmouth Medical Center Lakewood, New Jersey, United States

RWJBarnabas Health - Monmouth Medical Center Southern Campus Lakewood, New Jersey, United States

Cooperman Barnabas Medical Center Livingston, New Jersey, United States

View Trial Details

Completed

Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

NCT04362839

Conditions: Advanced Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

NCT03436563

Conditions: Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +27 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

NCT04752267

Conditions: Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8, Brain Diseases, +65 more
Locations: USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Active, Not Recruiting

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

NCT04599140

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +31 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

NCT05038254

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +71 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Active, Not Recruiting

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

NCT04616183

Conditions: Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +41 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Stage IVA Colon Cancer AJCC v8

Stage IVA Colon Cancer AJCC v8 trial results

Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy Delivery

Regorafenib, Ipilimumab and Nivolumab for the Treatment of Chemotherapy Resistant Microsatellite Stable Metastatic Colorectal Cancer

M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial

Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Related conditions